 |
|
Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
Young Seok Kim, Eun Sun Jung, Wonhee Hur, Si Hyun Bae, Jong Young Choi, Myeong Jun Song, Chang Wook Kim, Se Hyun Jo, Chang Don Lee, Young Sok Lee, Sang Wook Choi, Jin Mo Yang, Jeong Won Jang, Sang Gyune Kim, Seung Won Jung, Hee Kyung Kim, Hee Bok Chae, Seung Kew Yoon
Clin Mol Hepatol. 2013;19(2):120-130. Published online 2013 Jun 27 DOI: https://doi.org/10.3350/cmh.2013.19.2.120
|
|
Citations to this article as recorded by
 Thyroid hormone Beta receptor agonists for treatment of kidney disease: A promising agent?
Sidar Copur, Furkan Yavuz, Mehmet Kanbay
European Journal of Clinical Investigation.2023;[Epub] CrossRef Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
Huai Zhang, Rafael S. Rios, Jerome Boursier, Rodolphe Anty, Wah-Kheong Chan, Jacob George, Yusuf Yilmaz, Vincent Wai-Sun Wong, Jiangao Fan, Jean-François Dufour, George Papatheodoridis, Li Chen, Jörn M. Schattenberg, Jun-ping Shi, Liang Xu, Grace Lai-Hung
Chinese Medical Journal.2023;[Epub] CrossRef From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
Andrea Boccatonda, Lorenzo Andreetto, Damiano D’Ardes, Giulio Cocco, Ilaria Rossi, Susanna Vicari, Cosima Schiavone, Francesco Cipollone, Maria Teresa Guagnano
Biomedicines.2023; 11(3): 883. CrossRef Crosstalk between kidney and liver in non-alcoholic fatty liver disease: mechanisms and therapeutic approaches
Nisha Sharma, Anannya Sircar, Hans-Joachim Anders, Anil Bhanudas Gaikwad
Archives of Physiology and Biochemistry.2022; 128(4): 1024. CrossRef Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
Sina Ghandian, Rahul Thapa, Anurag Garikipati, Gina Barnes, Abigail Green‐Saxena, Jacob Calvert, Qingqing Mao, Ritankar Das
JGH Open.2022; 6(3): 196. CrossRef Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review
Huanqiu Wang, Ruyu Sun, Sisi Yang, Xueqing Ma, Chengbo Yu
Frontiers in Medicine.2022;[Epub] CrossRef Heterogeneity of non-alcoholic fatty liver disease (NAFLD): Implication for cardiovascular risk stratification
Francesco Baratta, Laura D'Erasmo, Simone Bini, Daniele Pastori, Francesco Angelico, Maria Del Ben, Marcello Arca, Alessia Di Costanzo
Atherosclerosis.2022; 357: 51. CrossRef Serum ferritin level as a noninvasive marker for detection and staging of hepatocellular injury, liver fibrosis, and steatosis in children and adolescents with nonalcoholic fatty liver disease
Ahmed A. Hassan, Mohiee E.-D.A. El-Aziz Awad, Hanan H. Soliman, Reda A.F. Usef, Dina S. Ata
Alexandria Journal of Pediatrics.2021; 34(3): 253. CrossRef Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis
Jenny Lee, Yasaman Vali, Jérôme Boursier, Kevin Duffin, Joanne Verheij, M. Julia Brosnan, Koos Zwinderman, Quentin M. Anstee, Patrick M. Bossuyt, Mohammad Hadi Zafarmand, Pavel Strnad
PLOS ONE.2020; 15(9): e0238717. CrossRef Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
Jung Gil Park, Gyeonghwa Kim, Se Young Jang, Yu Rim Lee, Eunhye Lee, Hye Won Lee, Man-Hoon Han, Jae Min Chun, Young Seok Han, Jun Sik Yoon, Min Kyu Kang, Young Oh Kweon, Won Young Tak, Soo Young Park, Keun Hur
Life.2020; 10(10): 230. CrossRef Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis
Pauline Verhaegh, Roisin Bavalia, Bjorn Winkens, Ad Masclee, Daisy Jonkers, Ger Koek
Clinical Gastroenterology and Hepatology.2018; 16(6): 837. CrossRef Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes, Homie Razavi, Rohit Loomba, Zobair Younossi, Arun J. Sanyal
Hepatology.2018; 67(1): 123. CrossRef Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
Chris Estes, Quentin M. Anstee, Maria Teresa Arias-Loste, Heike Bantel, Stefano Bellentani, Joan Caballeria, Massimo Colombo, Antonio Craxi, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V.
Journal of Hepatology.2018; 69(4): 896. CrossRef Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD
Peter Lykke Eriksen, Karen Louise Thomsen, Tea Lund Laursen, Konstantin Kazankov, Sara Heebøll, Henning Grønbæk
Current Hepatology Reports.2017; 16(4): 308. CrossRef Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD
Rosa Lombardi, Giuseppina Pisano, Silvia Fargion
International Journal of Molecular Sciences.2016; 17(4): 548. CrossRef NAFLD and Chronic Kidney Disease
Morgan Marcuccilli, Michel Chonchol
International Journal of Molecular Sciences.2016; 17(4): 562. CrossRef Evaluation of Serum Perforin, Caspase-3, sFasL and M-30 Levels as Apoptotic Markers in Children With Crimean-Congo Hemorrhagic Fever
Ahmet S. Güven, Enver Sancakdar, Elif B. Uysal, Ali Kaya, Mehmet B. Oflaz, Hekim Karapinar, Fatih Bolat, Nevin Tuzcu, Köksal Deveci, Ömer Cevit, Füsun D. İcagasioglu
Pediatric Infectious Disease Journal.2015; 34(2): 208. CrossRef The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis
Chuan Shen, Cai-Yan Zhao, Wei Wang, Ya-Dong Wang, Hui Sun, Wei Cao, Wei-Yan Yu, Li Zhang, Ru Ji, Meng Li, Jian Gao
BMC Gastroenterology.2014;[Epub] CrossRef Clinical Correlation between Serum Cytokeratin-18 and Metabolic Parameters in Patients with Sonographic Non-alcoholic Fatty Liver Disease
Dong Shin Kwak, Dae Won Jun, Yong Kyun Cho, Seung Min Lee, Se Hwan Lee, In Sub Jung, Sung Won Lee, Jae Keun Park, JungHoon Lee, Eun Young Lee, Min Rho, Kang Lok Lee, Jun Kwon Ko, Soon-Eung Park
The Korean Journal of Gastroenterology.2014; 64(4): 206. CrossRef Comparison on the Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid in Patients with Abnormal Alanine Aminotransferase: Multicenter, Double-blinded, Randomized, Active-controlled Clinical Trial
Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Young Don Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
The Korean Journal of Gastroenterology.2014; 64(1): 31. CrossRef The Clinical Significance of Serum Ferritin in Pediatric Non-Alcoholic Fatty Liver Disease
Ji Hoon Na, So Won Park, Yunkoo Kang, Hong Koh, Seung Kim
Pediatric Gastroenterology, Hepatology & Nutrition.2014; 17(4): 248. CrossRef The Wide and Complex Field of NAFLD Biomarker Research: Trends
Erika Wichro, Tanja Macheiner, Jasmin Schmid, Barbara Kavsek, Karine Sargsyan
ISRN Hepatology.2014; 2014: 1. CrossRef Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso, Roberto Gambino, James H. Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar
PLoS Medicine.2014; 11(7): e1001680. CrossRef Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
Goh Eun Chung, Donghee Kim
Clinical and Molecular Hepatology.2013; 19(2): 116. CrossRef
|